Several studies had showed that high levels of CD36 present in pre-diabetes, overt diabetes, polycystic ovary syndrome (PCOS), and impaired glucose tolerance strongly suggest that CD36 is involved in diabetes [30] and atherosclerosis pathogenesis and acts as inflammation biomarker [31, 32]. Here, CD36 is linked to Impaired glucose tolerance.